Dr. Mitchell Hayes received a 2024 Kidney Cancer Association Trailblazer Award in partnership with the Michael and Ina Korek Foundation for research on “Tracing the Seeds of Progression: Spatial Transcriptomic Analysis of Immunoresistant Kidney Cancer”….
Dr. Elizabeth Ellis received a 2024 Kidney Cancer Association Chromophobe RCC Focus Award in partnership with the Chromophobe and Oncocytic Tumor Alliance for research on “Evaluating the Response of Chromophobe Renal Cell Carcinoma to Novel…
We rounded up a few research highlights from the 2024 Congress of the European Society for Medical Oncology (ESMO), held recently in Madrid, Spain. Belzutifan continues to outperform targeted therapy in advanced kidney cancer Belzutifan outperformed targeted…
People with metastatic kidney cancer who already received one or two lines of treatment that included immunotherapy did not fare better when offered an additional round of immunotherapy after their cancer progressed. The results from…
The 2024 International Kidney Cancer Symposium (IKCS): North America, taking place in Louisville, Kentucky on November 7-9, will feature three special awards recognizing outstanding leaders in kidney cancer. Register now.
This is a guest post by Liam Piscetelli, the KCA’s 2024 Research Intern. For the past 8 months, I have interned with the KCA as a research intern. As a student working towards their Masters…
Jamie Graves is a kidney cancer advocate and member of the Kidney Cancer Association’s Board of Directors since 2017. She is running the 2024 Chicago Marathon to support kidney cancer research. Learn more about Jamie’s…
This is a guest post by Mark Dyson, 39, whose wife Dawn is diagnosed with translocation renal cell carcinoma. Mark, who lives with his family in England, is preparing to run an ultramarathon on September…
This is a guest post by Christopher G. Wood, Jr, son of the KCA’s late Board Chair and friend, Dr. Christopher G. Wood, a world-renown urology surgeon at MD Anderson Cancer Center in Houston, Texas….
This is a guest post by Teri Wight, 51, a teacher and a chromophobe renal cell carcinoma survivor based in Arizona. Read her other blog post “Just Shy of a Decade and Still Learning.” At…
